YOOZ Showcases Mini and Energy Series at Vaper Expo UK 2022

Oct.07.2022
YOOZ Showcases Mini and Energy Series at Vaper Expo UK 2022
The Vaper Expo UK 2022 showcased top Chinese e-cigarette brands, including YOOZ and their popular mini and ENERGY series products.

The Vaper Expo UK, a prominent electronic cigarette exhibition, is set to take place from October 7-9, 2022, in the United Kingdom. Among the participants are several Chinese electronic cigarette brands, including the well-known YOOZ brand, showcasing their mini and ENERGY product lines.


Yuzu Booth: Be Yourself and More


The staff members of YOOZ stated that their Mini 1+2 interchangeable cartridge series is their flagship product, with a focus on offering cost-effective solutions. The beginner's kit, which includes one vape pen and two pods, retails for £7.99 and is currently available through major distributors in the UK. During the exhibition, YOOZ Mini was discounted to £5 per kit, and customers could purchase three kits for £10.


Yuzu promotes mini 1+2 cartridge-based product. Possible Translation: Yuzu is promoting a new product that features an interchangeable cartridge system called mini 1+2. The citrus fruit company hopes this innovation will attract more customers and increase sales.


The YOOZ mini, which is available for sale in the UK, has been optimized for local users in terms of flavor. Fruit flavors now have a more pronounced sweetness. According to on-site tests and feedback, men generally prefer the taste of kiwi, while women tend to favor strawberry flavor.


Another interesting product, YOOZ ENERGY, although named "DISPOSABLE" and resembling a disposable product in appearance, still has a replaceable pod design. Each pod contains 2ml and can support up to 1200 puffs. It uses environmentally friendly materials and has a rechargeable battery, catering to the demands of the European market. However, its release status is currently unclear.


For further updates on the latest news regarding the Birmingham Electronic Cigarette Exhibition in the UK, click on the link below.


1. This article is intended solely for internal industry communication and discussion, and does not serve as a promotion or recommendation of any brand or product. 2. Smoking is detrimental to health. Minors are prohibited from reading this article.


This article is an original creation of Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and permission to use belong to the company, and no unit or individual may copy, reprint, or use it in any other way without authorization, violating the company's copyright. Violators will be subject to legal liability.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices
Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices
The Maine Legislature has passed LD 1519, a bill that would establish a producer-funded stewardship program for electronic smoking devices, requiring manufacturers and importers to manage the collection, transportation, recycling and disposal of end-of-life products, particularly disposable vapes containing lithium-ion batteries.
Jun.12
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).
Regulations
May.25